225
Views
6
CrossRef citations to date
0
Altmetric
Articles

Laminin-1 (LM-111) in preeclampsia and systemic lupus erythematosus

, , , , &
Pages 14-20 | Received 03 Feb 2012, Accepted 31 Aug 2012, Published online: 03 Dec 2012

References

  • Sibai B., Dekker G., Kupferminc M.. Pre-eclampsia. Lancet. 2005; 365:785–789.
  • Uriza G., López G., Riano G., Estrada A.. Estudio hospitalario de mortalidad materna (Estudio 400). Revista Colombiana de Obstetricia y Ginecología. 1982; 33:325–336.
  • Saftlas A. F., Beydoun H., Triche E.. Immunogenetic determinants of preeclampsia and related pregnancy disorders A systematic review. Obstet Gynecol. 2005; 106:162–172.
  • Gleicher N., Siegel I.. The immunologic concept of EPH-gestosis. Prog. Clin. Biol. Res. 1981; 70:229–243.
  • el-Roeiy A., Myers S. A., Gleicher N.. The relationship between autoantibodies and intrauterine growth retardation in hypertensive disorders of pregnancy. Am. J. Obstet. Gynecol. 1991; 164 5 Pt 1: 1253–1261.
  • McCarty D. J., Manzi S., Medsger T. A.Jr, . Incidence of systemic lupus erythematosus: Race and gender differences. Arthritis Rheum. 1995; 38:1260–1270.
  • Cooper G. S., Dooley M. A., Treadwell E. L., . Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum. 1998; 41:1714–1724.
  • Nelson J. L.. Maternal–fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune?. Arthritis Rheum. 1996; 39:191–194.
  • Cooper G. S., Dooley M. A., Treadwell E. L., St.Clair E. W., Gilkenson G. S.. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: Results of a population-based, case-control study. Arthritis Rheum. 2002; 46:1830–1839.
  • Jones J. C. R., Dehart G. W., Gonzales M., Goldfinger L. E.. Laminins: An overview. Microsc. Res. Tech. 2000; 51:211–213.
  • Ekblom P., Lonai P., Talts J. F.. Expression and biological role of laminin-1. Matrix Biol. 2003; 22:35–47.
  • Inagaki J., Sugiura-Ogasawara M., Nomizu M., . An association of IgG antilaminin-1 autoantibodies with endometriosis in infertile patients. Hum. Reprod. 2003; 18:544–549.
  • Peutz-Kootstra C. J., Hansen K., De Heer E., Abrass C. K., Bruijn J. A.. Diferential expression of laminin chains and anti-laminin autoantibodies in experimental lupus nephritis. J. Pathol. 2000; 192:404–412.
  • Pickering T. G., Hall J. E., Appel L. J., . Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005; 111:697–716.
  • Gifford R. W., August P. A., Cunningham F. G.. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure in Pregnancy. Am. J. Obstet. Gynecol. 2000; 183:S1–S22.
  • Serrano N. C., Casas J. P., Díaz L. A., . Endothelial nitric oxide synthase genotype and risk of preeclampsia: A multi-centre case-control study. Hypertension. 2004; 44:702–707.
  • Gladman D. D., Urowitz M. B., Goldsmith C. H., . The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum. 1997; 40:809–813.
  • Delgado-Vega A. M., Castiblanco J., Gómez L. M., . Bcl-2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women. Ann. Rheum. Dis. 2010; 69:462–465.
  • Kondo A., Inagaki J., Kobayashi K., . Characterization of a murine anti-laminin-1 monoclonal antibody (AK8) produced by immunization with mouse-derived laminin-1. Clin. Dev. Immunol. Mar. 2005; 12 1: 67–73.
  • Inagaki J., Matsuura E., Nomizu M., . IgG antilaminin- 1 autoantibody and recurrent miscarriages. Am. J. Reprod. Immunol. 2001; 45:232–238.
  • Greenland S.. Modeling and variable SLEection in epidemiologic analysis. Am. J. Public Health. 1989; 79:340–349.
  • Tsiatis A. A.. A note on a goodness-of-fit test for the logistic regression model. Biometrika. 1980; 67:250–251.
  • Matthiesen L., Berg G., Ernerudh J., . Immunology of preeclampsia. Chem. Immunol. Allergy. 2005; 89:49–61.
  • Smets E. M., Visser A., Go A. T., van Vugt J. M., Oudejans C. B.. Novel biomarkers in preeclampsia. Clin. Chim. Acta. 2006; 364:22–32.
  • Vinatier D., Prolongeau J. F., Dufour P., . Physiopathology of pre-eclampsia: the role of immunology. J. Gynecol. Obstet. Biol. Reprod. (Paris). 1995; 24:387–399.
  • Branch D. M., Andres R., Digre K. B., Rote N. S., Scott J. R.. The association of antiphospholipid antibodies with severe preeclampsia. Obstet. Gynecol. 1989; 73:541–545.
  • Yasuda M., Takakuwa K., Tokunaga A., Tanaka K.. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet. Gynecol. 1995; 86:555–559.
  • Martinez-Abundis E., Gonzalez-Ortiz M., Cortes-Lamas V., Salazar-Paramo M.. Anticardiolipin antibodies and the severity of preeclampsia–eclampsia. Gynecol. Obstet. Investig. 1999; 48:168–170.
  • Valdes-Macho E., Cabiedes J., Villa A., Cabral A., Alarcon-Segovia D.. Anticardiolipin and anti-b2-glycoprotein-I antibodies in hypertensive disorders of pregnancy. Arch. Med. Res. 2002; 33:460–465.
  • Foidart J. M., Risteli L., Boniver J., Goffinet G.. The basement membrane proteins laminin and type IV collagen in isolated villi in pre-eclampsia. Placenta. 1984; 5:541–550.
  • Inagaki J., Kondo A., Lopez L. R., Shoenfeld Y., Matsuura E.. Anti-laminin-1 autoantibodies, pregnancy loss and endometriosis. Clin. Dev. Immunol. 2004; 11:261–266.
  • Matalon S. T., Blank M., Matsuura E., . Immunization of naïve mice with mouse laminin-I affected pregnancy outcome in a mouse model. AJRI. 2003; 50:159–165.
  • Bieglmayer C., Feiks A., Rudelstorfer R.. Laminin in pregnancy. Gynecol. Obstet. Invest. 1986; 22:7–11.
  • Foidart J. M., Hunt J., Lapiere C. M., . Antibodies to laminin in preeclampsia. Kidney Int. 1986; 29:1050–1057.
  • Appella E., Furuhashi N., Kimura H., . Serum laminin levels in normal pregnancy and preeclampsia. Gynecol. Obstet. Invest. 1993; 36:172–175.
  • Páez M. C., González M. J., Serrano N. C., Shoenfeld Y., Anaya J. M.. Physiological and pathological implications of laminins: from the gene to the protein. Autoimmunity. 2007; 40:83–94.
  • Weber I. T., Blasi F.. Structure and function of epidermal growth factor-like regions in proteins. FEBS Lett. 1988; 231:1–4.
  • Moser K. L., Neas B. R., Salmon J. E., Yu H., Gray-Mcguire C., Asundi N., . Genome scan of human systemic lupus erythematosus: Evidence for linkage on chromosome 1q in African-American pedigrees. Proc. Natl. Acad. Sci. 1998; 95:14869–14874.
  • Johanneson B., Lima G., Salomé J., Alarcón-Segovia D., . A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31 Am. J. Hum. Genet. 2002; 71:1060–1071.
  • Hanrotel-Saliou C., Segalen I., Le Meur Y., Youinou P., Renaudineau Y.. Glomerular antibodies in lupus nephritis. Clin. Rev. Allergy Immunol. 2011; 40:151–158.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.